On the first day of the COVID-19 vaccination drive, over 40 lakh teenagers in the 15-18 age group received their first dose. As per the CoWIN portal, 40,02,782 teens were vaccinated till 8 pm.
Covaxin for Children Proven to be Safe in Phase II/III Study
Covaxin was proven to be safe, well-tolerated, in children who took part in phase II/III study.
Covaxin was proven to be safe, well-tolerated, in children who took part in phase II/III study.
‘As of now, only Bharat Biotech's indigenously-made 'Covaxin' will be available for vaccinating this age bracket. According to the Health Ministry, additional doses of Covaxin will be sent to all states and Union Territories for administering them to this population category.’
Union Health Minister Mansukh Mandaviya tweeted, "Well done, Young India! Over 40 lakhs between 15 and 18 received their first dose of COVID-19 vaccine on the 1st day of vaccination drive till 8 pm. This is another feather in the cap of India's vaccination drive." Prime Minister Narendra Modi had announced on December 25 that vaccination for the 15-18 age group would begin from January 3. The vaccination process of the third precautionary dose of vaccine for health workers, frontline workers, and vulnerable senior citizens will begin from January 10.
"Today, we have taken an important step forward in protecting our youth against COVID-19. Congrats to all my young friends between the age group of 15 and 18 who got vaccinated. Congrats to their parents as well. I would urge more youngsters to get vaccinated in the coming days," Modi tweeted on Monday.
Covaxin Gets Approval for Emergency Use for Children Aged 12-18
Bharat Biotech's Covaxin gets approval from the Drug Controller General of India (DGCI) for emergency use for children aged between 12-18 years.
Bharat Biotech's Covaxin gets approval from the Drug Controller General of India (DGCI) for emergency use for children aged between 12-18 years.
Opened COVID-19 Vaccine Covaxin Vial can be Stored for 28 Days
The opened vial of Bharat Biotech's coronavirus vaccine, Covaxin, can be stored at 2 to 8 degrees Celsius for up to 28 days. It is not required to be discarded immediately in a day or at the end of immunization session.
The opened vial of Bharat Biotech's coronavirus vaccine, Covaxin, can be stored at 2 to 8 degrees Celsius for up to 28 days. It is not required to be discarded immediately in a day or at the end of immunization session.
Covaxin 77.8% Per Cent Effective: Lancet
Covaxin is found to be 77.8% effective, reveal clinical trials. The vaccine maker Covaxin is the only Covid-19 vaccine to have demonstrated efficacy data from phase III clinical trials against the Delta variant at 65.2%.
Covaxin is found to be 77.8% effective, reveal clinical trials. The vaccine maker Covaxin is the only Covid-19 vaccine to have demonstrated efficacy data from phase III clinical trials against the Delta variant at 65.2%.
